Clinical Trial

Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis

Recruiting
View on ClinicalTrials.gov →
Summary
This is an observational study of patients with lupus nephritis aiming to find biomarkers that can predict patients' response to immunosuppressants. We planed to collect 100 lupus nephritis patients' peripheral blood,kidney tissues and urine before and after treatment (mycophenolate mofetil or cyclophosphamide, in combination with glucocorticoids). Then multi omics analysis, including single cell RNA-seq, ATAC-seq and CITE-seq, will be performed to find new biomarkers for patients' response and prognosis.
Trial Details
NCT Number NCT06167174
Lead Sponsor Chinese SLE Treatment And Research Group
Conditions Lupus Nephritis
Enrollment 100 participants
Start Date 2023-12-05
Primary Completion 2027-12-05 (estimated)
Study Completion 2028-12-05 (estimated)
Updated on ClinicalTrials.gov 2023-12-12